Advertisement

Prolidase as a marker of fibrogenesis in idiopathic primary ovarian insufficiency

  • Author Footnotes
    1 ORCID: 0000-0001-7686-9149.
    Esin Merve Erol Koc
    Correspondence
    Corresponding author at: Obstetrician and Gynecologist, Department of Obstetrics and Gynecology, Ankara City Hospital, Universiteler District, Bilkent Street, No:1, 06800 Cankaya/Ankara, Turkey.
    Footnotes
    1 ORCID: 0000-0001-7686-9149.
    Affiliations
    Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey
    Search for articles by this author
  • Author Footnotes
    2 ORCID: 0000-0003-1341-1370.
    Meryem Ceyhan
    Footnotes
    2 ORCID: 0000-0003-1341-1370.
    Affiliations
    Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey
    Search for articles by this author
  • Author Footnotes
    3 ORCID: 0000-0001-5247-6615.
    Selen Yaman
    Footnotes
    3 ORCID: 0000-0001-5247-6615.
    Affiliations
    Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey
    Search for articles by this author
  • Author Footnotes
    4 ORCID: 0000-0002-0974-5717.
    Salim Neselioglu
    Footnotes
    4 ORCID: 0000-0002-0974-5717.
    Affiliations
    Department of Biochemistry, Ankara Yıldırım Beyazıt University, Faculty of Medicine, Ankara, Turkey
    Search for articles by this author
  • Author Footnotes
    5 ORCID: 0000-0002-2996-3236.
    Ozcan Erel
    Footnotes
    5 ORCID: 0000-0002-2996-3236.
    Affiliations
    Department of Biochemistry, Ankara Yıldırım Beyazıt University, Faculty of Medicine, Ankara, Turkey
    Search for articles by this author
  • Author Footnotes
    6 ORCID: 0000-0001-9117-9728.
    Muzeyyen Gulnur Ozaksit
    Footnotes
    6 ORCID: 0000-0001-9117-9728.
    Affiliations
    Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey
    Search for articles by this author
  • Author Footnotes
    1 ORCID: 0000-0001-7686-9149.
    2 ORCID: 0000-0003-1341-1370.
    3 ORCID: 0000-0001-5247-6615.
    4 ORCID: 0000-0002-0974-5717.
    5 ORCID: 0000-0002-2996-3236.
    6 ORCID: 0000-0001-9117-9728.
Published:December 10, 2022DOI:https://doi.org/10.1016/j.ejogrb.2022.12.015

      Abstract

      Objectives

      To evaluate the serum level of prolidase, which is a marker of fibrogenic activity, in women with idiopathic primary ovarian insufficiency (POI).

      Study Design

      This is a prospective case-control study. Serum prolidase level was compared between the study group including 68 women with POI and control group including 65 normally menstruating women. Serum proline and hydroxyproline levels were also compared. Correlation analyses were performed between the prolidase level and POI related parameters including estradiol (E), follicle stimulating hormone (FSH), anti-mullerian hormone (AMH) levels, and presence of POI family history.

      Results

      Serum prolidase and proline level were significantly increased in women with the diagnosis of POI compared to the control group (1082.57 (147.53) vs 981.13 (223.26) U/L, 233.30 (83.16) vs 218.94 (82.59) µmol/L, respectively). Prolidase level found to have significant correlations with AMH, E, FSH levels, and presence of POI family history (r = −0.49, p = 0.001; r = −0.39, p = 0.001; r = 0.42, p = 0.001; r = 0.22, p = 0.01; respectively). In receiver operating characteristics analysis, prolidase was shown to be a discriminative factor for POI at 1031.14 U/L cut-off value with 75 % sensitivity and 65 % specificity. The area under curve was 0.71 [(95 % CI: 0.62–0.79), p = 0.001].

      Conclusion

      The current study revealed increased prolidase level in women with POI. Serum prolidase level was also negatively correlated with the serum AMH level. Considering the present findings, prolidase may be a candidate molecule in assessment of POI cases.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Committee opinion no
        605: primary ovarian insufficiency in adolescents and young women.
        Obstet Gynecol. 2014; 124: 193-197
        • Jin M.
        • Yu Y.
        • Huang H.
        An update on primary ovarian insufficiency.
        Sci China Life Sci. 2012; 55: 677-686
        • Kumar M.
        • Pathak D.
        • Venkatesh S.
        • Kriplani A.
        • Ammini A.C.
        • Dada R.
        Chromosomal abnormalities & oxidative stress in women with premature ovarian failure (POF).
        Indian J Med Res. 2012; 135: 92-97
        • Rafique S.
        • Sterling E.W.
        • Nelson L.M.
        A new approach to primary ovarian insufficiency.
        Obstet Gynecol Clin North Am. 2012; 39: 567-586
        • Chapman C.
        • Cree L.
        • Shelling A.N.
        The genetics of premature ovarian failure: current perspectives.
        Int J Womens Health. 2015; 7: 799-810
        • Zhou F.
        • Shi L.B.
        • Zhang S.Y.
        Ovarian fibrosis: a phenomenon of concern.
        Chin Med J (Engl). 2017; 130: 365-371
        • Huang Y.
        • Hu C.
        • Ye H.
        • Luo R.
        • Fu X.
        • Li X.
        • et al.
        Inflamm-aging: a new mechanism affecting premature ovarian insufficiency.
        J Immunol Res. 2019; 2019: 8069898
        • Namiduru E.S.
        Prolidase.
        Bratisl Lek Listy. 2016; 117: 480-485
        • Kayadibi H.
        • Gültepe M.
        • Yasar B.
        • Ince A.T.
        • Ozcan O.
        • Ipcioglu O.M.
        • et al.
        Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.
        Dig Dis Sci. 2009; 54: 1764-1771
        • Aslan M.
        • Duzenli U.
        • Esen R.
        • Soyoral Y.U.
        Serum prolidase enzyme activity in obese subjects and its relationship with oxidative stress markers.
        Clin Chim Acta. 2017; 473: 186-190
        • Yildiz A.
        • Demirbag R.
        • Yilmaz R.
        • Gur M.
        • Altiparmak I.H.
        • Akyol S.
        • et al.
        The association of serum prolidase activity with the presence and severity of coronary artery disease.
        Coron Artery Dis. 2008; 19: 319-325
        • Kitchener R.L.
        • Grunden A.M.
        Prolidase function in proline metabolism and its medical and biotechnological applications.
        J Appl Microbiol. 2012; 113: 233-247
        • Testing and interpreting measures of ovarian reserve
        a committee opinion.
        Fertil Steril. 2015; 103: 9-17
      1. European Society for Human Reproduction and Embryology (ESHRE) guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31:926–37.

        • Myara I.
        • Charpentier C.
        • Lemonnier A.
        Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria.
        Clin Chim Acta. 1982; 125: 193-205
        • Curry Jr., T.E.
        • Osteen K.G.
        Cyclic changes in the matrix metalloproteinase system in the ovary and uterus.
        Biol Reprod. 2001; 64: 1285-1296
        • Bakalov V.K.
        • Anasti J.N.
        • Calis K.A.
        • Vanderhoof V.H.
        • Premkumar A.
        • Chen S.
        • et al.
        Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46, XX spontaneous premature ovarian failure.
        Fertil Steril. 2005; 84: 958-965
        • Petríková J.
        • Lazúrová I.
        Ovarian failure and polycystic ovary syndrome.
        Autoimmun Rev. 2012; 11: 471-478
        • Vural M.
        • Camuzcuoglu H.
        • Toy H.
        • Camuzcuoglu A.
        • Aksoy N.
        Oxidative stress and prolidase activity in women with uterine fibroids.
        J Obstet Gynaecol. 2012; 32: 68-72
        • Celik A.
        • Birer M.N.
        • Kilinc M.
        Serum prolidase activity in systemic sclerosis.
        Clin Rheumatol. 2017; 36: 1827-1832
        • Bozkurt M.
        • Yüksel H.
        • Em S.
        • Oktayoglu P.
        • Yildiz M.
        • Akdeniz D.
        • et al.
        Serum prolidase enzyme activity and oxidative status in patients with Behçet's disease.
        Redox Rep. 2014; 19: 59-64
        • Ucar D.
        • Em S.
        • Bozkurt M.
        • Oktayoglu P.
        • Yuksel H.K.
        • Caglayan M.
        • et al.
        Serum prolidase activity in ankylosing spondylitis and rheumatoid arthritis.
        Clin Med Insights Arthritis Musculoskeletal Disord. 2013; 6: 29-33
        • Misiura M.
        • Miltyk W.
        Current Understanding of the emerging role of prolidase in cellular metabolism.
        Int J Mol Sci. 2020; 21: 5906
        • Liu R.M.
        • Gaston Pravia K.A.
        Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.
        Free Radic Biol Med. 2010; 48: 1-15
        • Surazynski A.
        • Miltyk W.
        • Prokop I.
        • Palka J.
        Prolidase-dependent regulation of TGF c and TGF β receptor expressions in human skin fibroblasts.
        Eur J Pharmacol. 2010; 649: 115-119
        • Coulam C.B.
        • Stern J.J.
        Immunology of ovarian failure.
        Am J Reprod Immunol. 1991; 25: 169-174
        • Irving-Rodgers H.F.
        • Rodgers R.J.
        Extracellular matrix of the developing ovarian follicle.
        Semin Reprod Med. 2006; 24: 195-203
        • Visser J.A.
        • Schipper I.
        • Laven J.S.
        • Themmen A.P.
        Anti-müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.
        Nat Rev Endocrinol. 2012; 8: 331-341
        • Eni-Aganga I.
        • Lanaghan Z.M.
        • Balasubramaniam M.
        • Dash C.
        • Pandhare J.
        Prolidase: a review from discovery to its role in health and disease.
        Front Mol Biosci. 2021; 8723003
      2. Phang J, Hu C-AA, Valle D. Disorders of proline and hydroxyproline metabolism. In: Valle DL, Antonarakis S, Ballabio A, Beaudet AL, Mitchell GA. eds. The Online Metabolic and Molecular Bases of Inherited Disease. McGraw Hill; 2019. Accessed July 25, 2022. https://ommbid.mhmedical.com/content.aspx?bookid=2709&sectionid=225083261.

        • Bachelot A.
        • Rouxel A.
        • Massin N.
        • Dulon J.
        • Courtillot C.
        • Matuchansky C.
        • et al.
        Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure.
        Eur J Endocrinol. 2009; 161: 179-187
        • Van Kasteren Y.M.
        • Hundscheid R.D.L.
        • Smits A.P.T.
        • Cremers F.P.M.
        • Van Zonneveld P.
        • Braat D.D.M.
        Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease?.
        Hum Reprod. 1999; 14: 2455-2459
        • Spodenkiewicz M.
        • Spodenkiewicz M.
        • Cleary M.
        • Massier M.
        • Fitsialos G.
        • Cottin V.
        • et al.
        Clinical genetics of prolidase deficiency: an updated review.
        Biology (Basel). 2020; 9: 108
        • Szeliga A.
        • Calik-Ksepka A.
        • Maciejewska-Jeske M.
        • Grymowicz M.
        • Smolarczyk K.
        • Kostrzak A.
        • et al.
        Autoimmune diseases in patients with premature ovarian insufficiency-our current state of knowledge.
        Int J Mol Sci. 2021; 22: 2594